
GSK News
GSK plc
$47.89
-$0.69(-1.42%)
24
Overall
--
Value
27
Tech
21
Quality
Market Cap
$99.84B
Volume
1.77M
52W Range
$45.81 - $61.70
Target Price
$58.46
GSK news: the latest GSK plc headlines, press releases and market updates, newest first.
Latest GSK News
- GSK Receives Japanese Orphan Drug Designation for Velzatinib in GISTTipRanks Auto-Generated Newsdesk · Nov 19, 2026
- GSK Updates Long-Term Linerixibat Study as Investor Focus Turns to Next StepsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 18, 2026
- GSK Updates EGPA Drug Study as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 18, 2026
- RBC Capital Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Nov 18, 2026
- GSK Advances New Two-Drug COPD Study as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 17, 2026
- Jefferies Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Nov 17, 2026
- GSK Advances Phase 3 Trial for Nasal-Polyp TreatmentTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 16, 2026
- GSK Advances Rectal Cancer Study as Investors Await RecruitmentTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 16, 2026
- GSK Updates NASH Drug Study as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 12, 2026
- GSK Reports Five PDMRs’ Share Reward Plan AcquisitionsTipRanks Auto-Generated Newsdesk · Nov 12, 2026
- Deutsche Bank Remains a Hold on GlaxoSmithKline (GSK)TipRanks Auto-Generated Intelligence Newsdesk · Nov 10, 2026
- Goldsky Ends Liquidity Provider Agreement as Trading ImprovesTipRanks Canadian Auto-Generated Newsdesk · Nov 6, 2026
- GSK Publishes Provisional 2027 Dividend ScheduleTipRanks Auto-Generated Newsdesk · Nov 6, 2026
- GSK Advances Early Ulcerative Colitis Study as Investors Watch Pipeline PotentialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- GSK’s Nasal-Polyp Trial Advances, but Investors Await DataTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- GSK Advances Phase 3 Asthma Trial, but Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- GSK Advances Liver Disease Drug Study as Investors Await Proof of BenefitTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- GSK Tracks Long-Term Potential of Its Shigella VaccineTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- GSK Advances Inhaler Propellant Safety Study as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- HP Hires Ex-GSK Boss as CEO amid Memory Chip Crunch; HPQ Stock FlatSolomon Oladipupo · Nov 4, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GSK | $47.89 | -1.4% | 1.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |